cell-isolation-and-separation-market

Cell Isolation and Separation Market By Product (Consumables, Instruments), By Technique (Surface Marker, Filtration, Centrifugation), By Type (Human Cells, Animal Cells), By Application (Research Laboratories & Institutes, Biotechnology and Biopharmaceutical Companies, Cell Banks, Hospital & Diagnostic Laboratories) - Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

28 Apr 2022 Format PDF icon PPT icon XLS icon Request Sample

Cell isolation & separation is the process of separating individual living cells from another within a biological sample such as blood or tissue. Cell isolation & separation techniques comprise centrifugation, FACS (fluorescence-activated cell sorting), BACS (buoyancy-activated cell sorting), MACS (magnetic-activated cell sorting), and microfluidics or filtration. There are three types of cell separation approaches such as positive selection, negative selection, and depletion. Increasing funding from the government and biotechnology companies for cell-based research coupled with growing biotechnology and biopharmaceutical companies are supporting the market growth. For instance, in 2017, the National Institutes of Health (NIH) invested US$ 1,646 Mn in stem cells research, which is projected to be spent by 2019. In addition, globally rising prevalence of cancer & infectious diseases along with augmenting demand for personalized medicine are anticipated to assist in the market growth during the forecast period.

The consumables segment is expected to spearhead the market owing to repetitive demand for these products for research & diagnostics application due to their limited durability. Increasing adoption of centrifugation technology for manufacturing of biopharmaceutical drugs, proteins, vaccines, and antibodies shall hold a major chunk of the market in the near future. Based on type, the human cells segment dominates the market due to rising applications of isolated human cells in biopharmaceuticals development, research, and clinical trials.

The presence of major market participants, biopharmaceutical companies & research laboratories along with sophisticated infrastructure in the U.S. and Canada has placed North America at the dominant position. On the other hand, Asia Pacific is expected to register comparatively higher CAGR from 2024 to 2032 due to rising prevalence of cancer and infectious diseases among individuals and favorable government support for research activities.

Increase in Prevalence of Chronic Diseases Driving Global Market

Rise in chronic diseases such as diabetes, obesity, arthritis, cardiac diseases, and cancer is increasing due to sedentary lifestyle, aging of the global population, and rise in alcohol consumption and cigarette smoking. 

Key Developments:

  • On April 19, 2023, Applied Cells, Inc. and STEMCELL Technologies Canada, Inc. announced collaboration to deliver a new high-performance cell separation solution that combines Applied Cells' MARS platform with STEMCELL's EasySep immunomagnetic cell separation kits. This partnership will help researchers across the world to automate and increase the efficiency of isolating high-quality cells from a wide range of sample types such as whole blood, bone marrow, apheresis products, and dissociated tissue.
  • On May 6, 2023, Akadeum Life Sciences, Inc., a global leader in buoyancy-based technology in cell therapy manufacturing, clinical diagnostics, and cell & molecular research for human health and life sciences, announced the diversification of its cell separation product portfolio with a new human B cell isolation product and updated protocol for its existing human isolation kits. Akadeum Life Sciences, Inc. will be on-hand to demonstrate the new protocol and kit, which leverages the company’s microbubble-based, cell sorting technology platform for high performance and simpler workflows.

Key players identified in the global cell isolation and separation market include:

  • Thermo Fisher Scientific Inc.
  • BD Biosciences
  • STEMCELL Technologies Inc.
  • Merck KGaA
  • GE Healthcare
  • Bio-Rad Laboratories, Inc.
  • Terumo BCT, Inc.
  • pluriSelect Life Science UG (haftungsbeschränkt) & Co. KG
  • Miltenyi Biotec GmbH
  • BioLegend, Inc. 

Historical & Forecast Period

This study report represents analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Cell Isolation and Separation market are as follows:

  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value.
  • Geographical revenues generate by countries considered in the report
  • Micro and macro environment factors that are currently influencing the Cell Isolation and Separation market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

ATTRIBUTE DETAILS
Research Period  2022-2032
Base Year 2023
Forecast Period  2024-2032
Historical Year  2022
Unit  USD Million
Segmentation
Product
  • Consumables
    •     Media, Reagents, Kits & Sera
    •     Beads
    •     Disposables
  • Instruments
    •     Centrifuges
    •     Flow Cytometers
    •     Magnetic-activated Cell Sorting (MACS) Systems
    •     Filtration Systems

Technique
  • Surface Marker
  • Filtration
  • Centrifugation

Type
  • Human Cells
  • Animal Cells

Application
  • Research Laboratories & Institutes
  • Biotechnology and Biopharmaceutical Companies
  • Cell Banks
  • Hospital & Diagnostic Laboratories

 Region Segment (2022-2032; US$ Million)

  • North America
    • U.S.
    • Canada
    • Rest of North America
  • UK and European Union
    • UK
    • Germany
    • Spain
    • Italy
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Key questions answered in this report

  • What are the key micro and macro environmental factors that are impacting the growth of Cell Isolation and Separation market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2032.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Cell Isolation and Separation market?
  • Which is the largest regional market for Cell Isolation and Separation market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Cell Isolation and Separation market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Cell Isolation and Separation market worldwide?
Choose Licence Type
$4500
$6500
$9000
Why Acute
View Other Reports